Kritchanut / iStock
Johnson & Johnson has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott.
The all-cash $4.325 billion acquisition was originally announced in September 2016, and includes ophthalmic products in three areas of patient care: cataract surgery, laser refractive surgery and consumer eye health.
"With the addition of AMO's world-renowned ophthalmic surgery business, J&J Vision is poised to become a world leader in eye health," said Ashley McEvoy, group chairman of Johnson & Johnson Consumer Medical Devices.
"Sight is precious, it's the sense people fear losing the most. By bringing on board surgical solutions that are supported by the resources and global reach of Johnson & Johnson, we can improve and restore sight for more patients across the globe."
Johnson & Johnson, Acquisition, Abbott Medical, US